## Chronic Gout Management: Urate-Lowering Therapy Initiation **Key Point:** Chronic gout with tophaceous deposits requires urate-lowering therapy (ULT) to prevent future attacks and dissolve tophi. Prophylaxis with anti-inflammatory agents MUST accompany ULT initiation to prevent acute flares. ### Indications for ULT in Gout **High-Yield:** ULT is indicated when: - ≥2 gout attacks per year, OR - Chronic tophaceous gout (tophi visible on examination or imaging), OR - Gout with chronic kidney disease, OR - Uric acid nephrolithiasis This patient has **tophaceous gout**—a clear indication for ULT. ### First-Line ULT Agents: Comparison | Agent | Mechanism | Starting Dose | Target | Advantages | Disadvantages | |-------|-----------|---------------|--------|------------|---------------| | **Allopurinol** | Xanthine oxidase inhibitor | 50–100 mg daily | <6 mg/dL | First-line, inexpensive, well-tolerated | HLA-B*5801 risk (severe reactions in certain populations); slow titration needed | | **Febuxostat** | Selective xanthine oxidase inhibitor | 40 mg daily | <6 mg/dL | More selective; faster titration possible | Newer, more expensive; cardiovascular risk in some studies | | **Probenecid** | Uricosuric (↑ renal excretion) | 500 mg daily | <6 mg/dL | Useful if uric acid underexcretion predominates | Contraindicated in renal impairment (eGFR <50); risk of uric acid stones | **Clinical Pearl:** Allopurinol remains the gold standard first-line ULT due to efficacy, safety, and cost. It should be started at a low dose (50–100 mg daily) and titrated slowly (every 2–4 weeks) to avoid acute flares. ### Prophylaxis During ULT Initiation: Essential Step **Warning:** Starting ULT without prophylaxis causes acute flares in 50–80% of patients. Prophylaxis MUST be given for 3–6 months during ULT initiation. **Prophylaxis options:** 1. **Colchicine 0.5 mg daily** (preferred if tolerated) 2. **NSAID** (e.g., indomethacin 25–50 mg daily) if colchicine contraindicated 3. **Low-dose corticosteroid** (prednisolone 5–10 mg daily) if both above contraindicated ### Management Algorithm ```mermaid flowchart TD A[Chronic Gout with Tophi]:::outcome --> B[Indication for ULT?]:::decision B -->|Yes| C[Start ULT: Allopurinol 50-100 mg daily]:::action C --> D[Add prophylaxis: Colchicine 0.5 mg daily]:::action D --> E[Titrate allopurinol every 2-4 weeks]:::action E --> F{Serum urate < 6 mg/dL?}:::decision F -->|No| G[Increase allopurinol dose]:::action G --> E F -->|Yes| H[Continue for 3-6 months]:::action H --> I[Discontinue prophylaxis]:::action I --> J[Maintain ULT indefinitely]:::action ``` **Mnemonic:** **ALLOPURINOL START = Slow, Low, Prophylaxis** (Slow titration, Low starting dose, Prophylaxis mandatory). ### Why Allopurinol Over Febuxostat Here? Allopurinol is preferred as first-line because: - Decades of safety data - Cost-effective - Equally effective for target uric acid <6 mg/dL - Febuxostat reserved for allopurinol intolerance or inadequate response [cite:Harrison 21e Ch 356; KD Tripathi 8e Ch 18] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.